Enhancement of collective immunity in Tokyo metropolitan area by selective vaccination against an emerging influenza pandemic.
Vaccination is a preventive measure against influenza that does not require placing restrictions on social activities. However, since the stockpile of vaccine that can be prepared before the arrival of an emerging pandemic strain is generally quite limited, one has to select priority target groups to which the first stockpile is distributed. In this paper, we study a simulation-based priority target selection method with the goal of enhancing the collective immunity of the whole population. To model the region in which the disease spreads, we consider an urban area composed of suburbs and central areas connected by a single commuter train line. Human activity is modelled following an agent-based approach. The degree to which collective immunity is enhanced is judged by the attack rate in unvaccinated people. The simulation results show that if students and office workers are given exclusive priority in the first three months, the attack rate can be reduced from [Formula: see text] in the baseline case down to 1-2%. In contrast, random vaccination only slightly reduces the attack rate. It should be noted that giving preference to active social groups does not mean sacrificing those at high risk, which corresponds to the elderly in our simulation model. Compared with the random administration of vaccine to all social groups, this design successfully reduces the attack rate across all age groups.
Institute of Statistical Mathematics, Tachikawa, Tokyo, Japan.
Masaya M
MM
Saito
Seiya
S
Imoto
Rui
R
Yamaguchi
Masaharu
M
Tsubokura
Masahiro
M
Kami
Haruka
H
Nakada
Hiroki
H
Sato
Satoru
S
Miyano
Tomoyuki
T
Higuchi
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003198:Computer Simulation; D005260:Female; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology; D007251:Influenza, Human / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D058873:Pandemics; D014041:Tokyo / Q000453:epidemiology; D014186:Transportation; D014505:Urban Population; D014611:Vaccination
D007252:Influenza Vaccines